Literature DB >> 8405780

Comparative carcinogenicity of 5,5-diphenylhydantoin with or without perinatal exposure in rats and mice.

R S Chhabra1, J R Bucher, J K Haseman, M R Elwell, P J Kurtz, B D Carlton.   

Abstract

Chronic toxicity and carcinogenicity studies of 5,5-diphenylhydantoin (DPH), were conducted in F344/N rats and B6C3F1 mice of each sex. The major objective of the study was to determine if incorporating exposure to DPH during the perinatal period, in addition to conventional exposure of animals for 2 years, enhances the sensitivity of the bioassay to identify the carcinogenic potential of chemical. The studies were designed to determine the toxic and carcinogenic effects of dietary DPH in rats and mice receiving; (1) the perinatal administration including exposure of maternal animals prior to breeding, through gestation, lactation, weaning, and continued dietary exposure of offspring to the age of 8 weeks followed by control diet for 2 years, (2) exposure for 2 years beginning at the age of 8 weeks, and (3) of combined perinatal/adult exposure to DPH (perinatal exposure to 8 weeks of age followed by the adult exposure for 2 years). During the perinatal period, rats were exposed to DPH at dose levels ranging from 63 to 630 ppm and adult exposure concentrations ranged from 240 to 2400 ppm in diet. In the mice, the perinatal exposure ranged from 21 to 210 ppm in both males and females. In the adult exposure portion of the mouse studies, the dietary levels ranged from 30 to 300 ppm in males and 60 to 600 ppm in females. A total of eight dose groups (including controls) were used with 60 animals in each group. The only effect of perinatal exposure alone on tumor rate was a marginal increase in the incidence of hepatocellular neoplasms in female mice. The adult exposure to DPH significantly increased the incidence of hepatocellular neoplasms in female mice. There were also marginal increases in the incidence of liver tumors in male rats exposed to high DPH dietary concentrations during the adult-only regimen. Combined perinatal and adult dietary exposure to 5,5-diphenylhydantoin confirmed the findings for the increased incidences of hepatocellular neoplasms in male rats and female mice, although combined exposure did not enhance these effects. However, in male mice, perinatal and adult exposure resulted in an increase in the incidence of hepatocellular neoplasms that was not seen when dietary exposure was limited to the adult period only.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405780     DOI: 10.1006/faat.1993.1087

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  5 in total

Review 1.  Assessing susceptibility from early-life exposure to carcinogens.

Authors:  Hugh A Barton; V James Cogliano; Lynn Flowers; Larry Valcovic; R Woodrow Setzer; Tracey J Woodruff
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

Review 2.  Cancer and developmental exposure to endocrine disruptors.

Authors:  Linda S Birnbaum; Suzanne E Fenton
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

Review 3.  Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop.

Authors:  R J Kavlock; G P Daston; C DeRosa; P Fenner-Crisp; L E Gray; S Kaattari; G Lucier; M Luster; M J Mac; C Maczka; R Miller; J Moore; R Rolland; G Scott; D M Sheehan; T Sinks; H A Tilson
Journal:  Environ Health Perspect       Date:  1996-08       Impact factor: 9.031

4.  Commemorating Toxicology at the National Institute of Environmental Health Sciences on the Occasion of Its 50th Anniversary.

Authors:  John R Bucher; Linda S Birnbaum
Journal:  Environ Health Perspect       Date:  2016-11-01       Impact factor: 9.031

5.  Workgroup report: National Toxicology Program workshop on Hormonally Induced Reproductive Tumors - Relevance of Rodent Bioassays.

Authors:  Kristina A Thayer; Paul M Foster
Journal:  Environ Health Perspect       Date:  2007-09       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.